TIAA Trust National Association Sells 24,180 Shares of HCA Healthcare, Inc. (NYSE:HCA)

TIAA Trust National Association cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 94.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,542 shares of the company’s stock after selling 24,180 shares during the period. TIAA Trust National Association’s holdings in HCA Healthcare were worth $463,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in HCA. Whipplewood Advisors LLC bought a new position in HCA Healthcare in the fourth quarter worth $31,000. Tidemark LLC bought a new position in shares of HCA Healthcare in the 4th quarter worth about $36,000. Legacy Investment Solutions LLC bought a new stake in HCA Healthcare during the third quarter worth about $39,000. Activest Wealth Management lifted its holdings in shares of HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. grew its stake in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after buying an additional 50 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.30% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms have recently commented on HCA. Cantor Fitzgerald reissued an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. Barclays decreased their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a report on Monday, January 27th. Morgan Stanley reduced their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Royal Bank of Canada reduced their target price on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. Finally, KeyCorp dropped their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Price Performance

NYSE HCA opened at $342.25 on Friday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The business’s fifty day moving average is $324.53 and its 200 day moving average is $341.56. The company has a market capitalization of $84.26 billion, a PE ratio of 15.58, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the business posted $5.90 EPS. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.84%. HCA Healthcare’s dividend payout ratio is 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.